BackSino Biopharmaceutical Limited Overview

Sino Biopharmaceutical Limited Total Assets

Track Sino Biopharmaceutical Limited's total assets ($83B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$83.21B
↑ 11.10% YoYΔ $8.31B vs prior year quarter

Peer trimmed avg / median

Loading

Sino Biopharmaceutical Limited Total Assets History

Loading

Sino Biopharmaceutical Limited vs. peers: Total Assets Comparison

Loading

Sino Biopharmaceutical Limited Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sino Biopharmaceutical Limited (SBMFF) FAQ

As of the most recent data (June 2026), SBMFF shows a total assets of $83B. That compares with $75B in the prior-year period — up 11.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBMFF's total assets is now $83B (was $75B) — a 11.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sino Biopharmaceutical Limited is outperforming or lagging.

Tracking SBMFF's total assets over time shows whether Sino Biopharmaceutical Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $83B That compares with $75B in the prior-year period — up 11.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Sino Biopharmaceutical Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $83B) with ownership activity and broader fundamentals.

Sino Biopharmaceutical Limited's total assets is $83B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.